Article
A review on the role of gut microbiota in immune checkpoint blockade therapy for cancer
30 Mar 2021
Abstract excerpt
Gut microbiota has been studied in relation to human health and disease prediction for decades. Also, immune checkpoints (ICPs) are enthusiastically investigated for anti-tumor immunotherapy. Recent studies show potential of gut microbiome and gut cytokines as biomarkers for carcinogenesis and response prediction of immune checkpoint inhibitor (ICI) response. Evidence has revealed that intestinal microorganisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
